| Role of nitric oxide synthases in early blood-brain barrier disruption following transient focal cerebral ischemia Z Jiang, C Li, DM Arrick, S Yang, AE Baluna, H Sun PloS one 9 (3), e93134, 2014 | 82 | 2014 |
| Wnt/Beta-catenin signaling and prostate cancer therapy resistance Y Yeh, Q Guo, Z Connelly, S Cheng, S Yang, N Prieto-Dominguez, X Yu Prostate Cancer: Cellular and Genetic Mechanisms of Disease Development and …, 2019 | 74 | 2019 |
| Carvedilol promotes mitochondrial biogenesis by regulating the PGC-1/TFAM pathway in human umbilical vein endothelial cells (HUVECs) K Yao, WW Zhang, L Yao, S Yang, W Nie, F Huang Biochemical and biophysical research communications 470 (4), 961-966, 2016 | 57 | 2016 |
| The expression of YAP1 is increased in high-grade prostatic adenocarcinoma but is reduced in neuroendocrine prostate cancer S Cheng, N Prieto-Dominguez, S Yang, ZM Connelly, S StPierre, ... Prostate cancer and prostatic diseases 23 (4), 661-669, 2020 | 48 | 2020 |
| Quantification of bone changes in a collagen-induced arthritis mouse model by reconstructed three dimensional micro-CT S Yang, AM Hollister, EA Orchard, SI Chaudhery, DV Ostanin, SJ Lokitz, ... Biological procedures online 15, 1-8, 2013 | 28 | 2013 |
| Vigorous exercise training improves reactivity of cerebral arterioles and reduces brain injury following transient focal ischemia DM Arrick, S Yang, C Li, S Cananzi, WG Mayhan Microcirculation 21 (6), 516-523, 2014 | 27 | 2014 |
| Neuroendocrine prostate cancer has distinctive, non-prostatic HOX code that is represented by the loss of HOXB13 expression S Cheng, S Yang, Y Shi, R Shi, Y Yeh, X Yu Scientific reports 11 (1), 2778, 2021 | 23 | 2021 |
| Foxa2 activates the transcription of androgen receptor target genes in castrate resistant prostatic tumors ZM Connelly, S Yang, F Chen, Y Yeh, N Khater, R Jin, R Matusik, X Yu American journal of clinical and experimental urology 6 (5), 172, 2018 | 18 | 2018 |
| FOXA2 promotes prostate cancer growth in the bone ZM Connelly, R Jin, J Zhang, S Yang, S Cheng, M Shi, JMM Cates, R Shi, ... American journal of translational research 12 (9), 5619, 2020 | 16 | 2020 |
| Androgen receptor differentially regulates the proliferation of prostatic epithelial cells in vitro and in vivo. YX Yang S1, Jiang M2,3, Grabowska MM4, Li J1, Connelly ZM1, Zhang J4 ... Oncotarget, 2016 | 16 | 2016 |
| Micro-CT evaluation of rheumatoid arthritis mouse model disease progression: Manual tracings versus semi-automated routines AC Antill, DH Ballard, AM Hollister, EJ Rogers, S Yang, SJ Lokitz Diagnostic and Interventional Imaging 97 (6), 651-655, 2016 | 9 | 2016 |
| Expression of FOXA1 and EZH2 in breast cancer and association with clinicopathological features and TP53/RB1 alterations M Shi, S Yang, R Shi, S Cheng, L Lopez, X Yu LABORATORY INVESTIGATION 100 (SUPPL 1), 260-260, 2020 | 1 | 2020 |
| Functional role of EZH2 in neuroendocrine prostate cancer MI Khalil, S Yang, A Blankenship, Z Connelly, X Yu Cancer Research 79 (13_Supplement), 5191-5191, 2019 | 1 | 2019 |
| Significant Increase of Urine Fibrinogen in Mouse Model of Contrast-Induced Nephropathy WWZ Luyu Yao , Honglin Dong , Cynthia Zhao , Shu Yang JOURNAL OF VASCULAR SURGERY 59, 87S, 2014 | 1* | 2014 |
| STMN1 Expression is Elevated in Neuroendocrine Small Cell Carcinoma of the Prostate Y Yeh, Y Shi, S Cheng, S Yang, X Yu LABORATORY INVESTIGATION 102 (SUPPL 1), 1103-1104, 2022 | | 2022 |
| Refined HOX Codes for the Identification of the Origins of Cancer Cells Y Yeh, S Cheng, S Yang, Y Shi, X Yu LABORATORY INVESTIGATION 102 (SUPPL 1), 1102-1103, 2022 | | 2022 |
| MP33-18 LOSS OF FOXA2 IN NEUROENDOCRINE PROSTATE CANCER LEADS TO INDUCTION OF FUNCTIONAL ANDROGEN RECEPTOR ZM Connelly, S Yang, S Cheng, X Yu Journal of Urology 206 (Supplement 3), e613-e614, 2021 | | 2021 |
| Neuroendocrine cancer cells have changed HOX code during trans-differentiation S Cheng, S Yang, Y Shi, R Shi, Y Yeh, X Yu Cancer Research 81 (13_Supplement), 2151-2151, 2021 | | 2021 |
| Loss of YAP1 activates Wnt/beta-Catenin signaling in prostate cancer S Cheng, S Yang, N Prieto-Dominguez, ZM Connelly, Y Shi, X Yu Cancer Research 80 (16_Supplement), 4861-4861, 2020 | | 2020 |
| Loss of HOXB13 expression in neuroendocrine prostate cancer S Cheng, S Yang, Y Shi, R Shi, Y Yeh, X Yu bioRxiv, 2020.07. 03.187302, 2020 | | 2020 |
J. Michael MathisUniversity of North Texas Health Science CenterVerified email at crimson.ua.edu